PT Soho Global Health Tbk (SOHO.JK)
IDR 635.0
(0.0%)
IDR 635.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 19.94 Billion IDR | -5.13% |
| 2022 | 21.02 Billion IDR | -12.94% |
| 2021 | 24.14 Billion IDR | -23.07% |
| 2020 | 31.39 Billion IDR | -93.9% |
| 2019 | 514.21 Billion IDR | 6.67% |
| 2018 | 482.04 Billion IDR | 6.44% |
| 2017 | 452.88 Billion IDR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 6.39 Billion IDR | -13.6% |
| 2024 Q1 | 15.29 Billion IDR | -23.35% |
| 2024 Q2 | 14.18 Billion IDR | -7.23% |
| 2023 Q4 | 19.94 Billion IDR | 10.6% |
| 2023 FY | 19.94 Billion IDR | -5.13% |
| 2023 Q3 | 18.03 Billion IDR | -10.44% |
| 2023 Q2 | 20.13 Billion IDR | -10.39% |
| 2023 Q1 | 22.47 Billion IDR | 6.88% |
| 2022 Q3 | 27.22 Billion IDR | 4.83% |
| 2022 Q2 | 25.97 Billion IDR | 14.18% |
| 2022 Q1 | 22.74 Billion IDR | -5.8% |
| 2022 FY | 21.02 Billion IDR | -12.94% |
| 2022 Q4 | 21.02 Billion IDR | -22.78% |
| 2021 Q4 | 24.14 Billion IDR | -4.75% |
| 2021 Q3 | 25.35 Billion IDR | -8.93% |
| 2021 Q2 | 27.84 Billion IDR | -3.66% |
| 2021 Q1 | 28.89 Billion IDR | 19.13% |
| 2021 FY | 24.14 Billion IDR | -23.07% |
| 2020 Q4 | 24.25 Billion IDR | 19.72% |
| 2020 Q1 | 543.78 Billion IDR | 5.75% |
| 2020 FY | 31.39 Billion IDR | -93.9% |
| 2020 Q3 | 20.26 Billion IDR | 0.0% |
| 2019 Q4 | 514.21 Billion IDR | 0.0% |
| 2019 FY | 514.21 Billion IDR | 6.67% |
| 2019 Q1 | - IDR | 0.0% |
| 2018 FY | 482.04 Billion IDR | 6.44% |
| 2017 FY | 452.88 Billion IDR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 3.08 Billion IDR | -545.785% |
| PT Itama Ranoraya Tbk | 240.86 Billion IDR | 91.718% |
| PT Kimia Farma (Persero) Tbk | 7926.98 Billion IDR | 99.748% |
| PT Millennium Pharmacon International Tbk | 710.33 Billion IDR | 97.192% |